Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atze T Das

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
Cell Reports|December 16, 2016
A Combinatorial CRISPR-Cas9 Attack on HIV-1 DNA Extinguishes All Infectious Provirus in Infected T Cell CulturesGang Wang, Na Zhao, Ben Berkhout, et al.
Antimicrobial Agents and Chemotherapy|September 13, 2017
Combinatorial CRISPR-Cas9 and RNA Interference Attack on HIV-1 DNA and RNA Can Lead to Cross-ResistanceNa Zhao, Gang Wang, Atze T Das, et al.
Journal of Virology|July 4, 2008
Functional analysis of the complex trans-activating response element RNA structure in simian immunodeficiency virusMireille Centlivre, Bep Klaver, Ben Berkhout, et al.
The Journal of General Virology|September 20, 2015
Human immunodeficiency virus type 1 splicing at the major splice donor site is controlled by highly conserved RNA sequence and structural elementsNancy Mueller, Bep Klaver, Ben Berkhout, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 23, 2016
CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus EscapeGang Wang, Na Zhao, Ben Berkhout, et al.
Virus Research|August 2, 2017
CRISPR-Cas based antiviral strategies against HIV-1Gang Wang, Na Zhao, Ben Berkhout, et al.
Retrovirology|February 13, 2009
Destabilization of the TAR hairpin leads to extension of the polyA hairpin and inhibition of HIV-1 polyadenylationMartine M Vrolijk, Alex Harwig, Ben Berkhout, et al.
Journal of Virology|February 26, 2005
Improving the safety of a conditional-live human immunodeficiency virus type 1 vaccine by controlling both gene expression and cell entryAtze T Das, Chris E Baldwin, Monique Vink, et al.
Journal of Virology|May 1, 2023
HIV-1 3'-Polypurine Tract Mutations Confer Dolutegravir Resistance by Switching to an Integration-Independent Replication Mechanism via 1-LTR CirclesJosé G Dekker, Bep Klaver, Ben Berkhout, et al.
Antimicrobial Agents and Chemotherapy|October 11, 2021
Mutations in the HIV-1 3'-Polypurine Tract Can Confer Dolutegravir ResistanceJosé G Dekker, Bep Klaver, Ben Berkhout, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Cell Reports|December 16, 2016
A Combinatorial CRISPR-Cas9 Attack on HIV-1 DNA Extinguishes All Infectious Provirus in Infected T Cell CulturesGang Wang, Na Zhao, Ben Berkhout, et al.
Antimicrobial Agents and Chemotherapy|September 13, 2017
Combinatorial CRISPR-Cas9 and RNA Interference Attack on HIV-1 DNA and RNA Can Lead to Cross-ResistanceNa Zhao, Gang Wang, Atze T Das, et al.
Journal of Virology|July 4, 2008
Functional analysis of the complex trans-activating response element RNA structure in simian immunodeficiency virusMireille Centlivre, Bep Klaver, Ben Berkhout, et al.
The Journal of General Virology|September 20, 2015
Human immunodeficiency virus type 1 splicing at the major splice donor site is controlled by highly conserved RNA sequence and structural elementsNancy Mueller, Bep Klaver, Ben Berkhout, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 23, 2016
CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus EscapeGang Wang, Na Zhao, Ben Berkhout, et al.
Virus Research|August 2, 2017
CRISPR-Cas based antiviral strategies against HIV-1Gang Wang, Na Zhao, Ben Berkhout, et al.
Retrovirology|February 13, 2009
Destabilization of the TAR hairpin leads to extension of the polyA hairpin and inhibition of HIV-1 polyadenylationMartine M Vrolijk, Alex Harwig, Ben Berkhout, et al.
Journal of Virology|February 26, 2005
Improving the safety of a conditional-live human immunodeficiency virus type 1 vaccine by controlling both gene expression and cell entryAtze T Das, Chris E Baldwin, Monique Vink, et al.
Journal of Virology|May 1, 2023
HIV-1 3'-Polypurine Tract Mutations Confer Dolutegravir Resistance by Switching to an Integration-Independent Replication Mechanism via 1-LTR CirclesJosé G Dekker, Bep Klaver, Ben Berkhout, et al.
Antimicrobial Agents and Chemotherapy|October 11, 2021
Mutations in the HIV-1 3'-Polypurine Tract Can Confer Dolutegravir ResistanceJosé G Dekker, Bep Klaver, Ben Berkhout, et al.
Pageof 9